NYSE:SQZ SQZ Biotechnologies (SQZ) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free SQZ Stock Alerts $0.05 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.05▼$0.0550-Day Range$0.04▼$0.0552-Week Range$0.25▼$3.56Volume16 shsAverage Volume455,220 shsMarket Capitalization$1.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media Get SQZ Biotechnologies alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About SQZ Biotechnologies Stock (NYSE:SQZ)SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.Read More SQZ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SQZ Stock News HeadlinesApril 22, 2024 | americanbankingnews.comReviewing BioAtla (NASDAQ:BCAB) and SQZ Biotechnologies (NYSE:SQZ)April 1, 2024 | bizjournals.comVC funding update: who raised money in March?April 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.March 19, 2024 | finance.yahoo.comPortal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VCDecember 28, 2023 | seekingalpha.comSQZB SQZ Biotechnologies CompanyDecember 12, 2023 | morningstar.comSQZ Biotechnologies Co Ordinary Shares SQZBNovember 8, 2023 | msn.comSQZ Biotechnologies GAAP EPS of -$0.80 misses by $0.30, revenue of $0MNovember 8, 2023 | finance.yahoo.comSQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio UpdatesApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.November 4, 2023 | morningstar.comLifeline Biotechnologies Inc LLBONovember 3, 2023 | finance.yahoo.comSQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual MeetingAugust 10, 2023 | finance.yahoo.comSQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio UpdatesAugust 3, 2023 | investing.comSqz Biotechnologies Co (SQZB)July 25, 2023 | benzinga.comSQZ Biotechnologies Provides Update on Collaboration with RocheJuly 3, 2023 | seekingalpha.comSQZ Biotechnologies to be delisted from the NYSEJuly 3, 2023 | finance.yahoo.comNYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ)June 15, 2023 | finance.yahoo.comSQZ Biotechnologies to Consolidate Shares with 1-for-10 Reverse Stock SplitMay 11, 2023 | markets.businessinsider.comH.C. Wainwright Reaffirms Their Hold Rating on SQZ Biotechnologies (SQZ)May 10, 2023 | finance.yahoo.comSQZ Biotechnologies Reports First Quarter 2023 Financial Results and Recent Portfolio UpdatesMay 10, 2023 | finance.yahoo.comSQZ Biotechnologies Company (SQZ) Reports Q1 Loss, Misses Revenue EstimatesApril 17, 2023 | finance.yahoo.comInvestors Aren't Entirely Convinced By SQZ Biotechnologies Company's (NYSE:SQZ) RevenuesMarch 29, 2023 | msn.comSQZ Biotechnologies's Return On Capital Employed InsightsMarch 24, 2023 | benzinga.comShort Volatility Alert: Sqz BiotechnologiesMarch 24, 2023 | markets.businessinsider.comBTIG Remains a Buy on SQZ Biotechnologies (SQZ)March 23, 2023 | finance.yahoo.comSQZ Biotech's Cancer Candidate Shows Response At Low Dose In HPV16+ Solid Tumor PatientMarch 22, 2023 | marketwatch.comStocks to Watch: Coinbase, Agile Therapeutics, Steelcase, SQZ BiotechnologiesMarch 22, 2023 | marketwatch.comSQZ Biotechnologies Shares Advance 44% on Continued AAC TrialSee More Headlines Receive SQZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SQZ Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNYSE:SQZ CUSIPN/A CIK1604477 Webwww.sqzbiotech.com Phone617-758-8672FaxN/AEmployees53Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.61) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-79,460,000.00 Net Margins-369.96% Pretax Margin-408.99% Return on Equity-119.83% Return on Assets-59.90% Debt Debt-to-Equity RatioN/A Current Ratio3.50 Quick Ratio3.50 Sales & Book Value Annual Sales$18.16 million Price / Sales0.08 Cash FlowN/A Price / Cash FlowN/A Book Value$1.94 per share Price / Book0.02Miscellaneous Outstanding Shares29,491,000Free Float24,772,000Market Cap$1.37 million OptionableNot Optionable Beta2.34 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Howard Bernstein M.D. (Age 66)Ph.D., Interim CEO & Director Comp: $552.14kMr. Lawrence J. Knopf Esq. (Age 61)Gen. Counsel Comp: $512.38kDr. Marshelle Smith Warren M.D. (Age 60)Chief Medical Officer Comp: $476.27kDr. Robert S. Langer Jr. (Age 74)Ph.D., Sc.D., SCD, Co-Founder & Member of Scientific Advisory Board Mr. Richard V. Capasso CPA (Age 61)Chief Accounting Officer Mr. David First (Age 59)Chief People Officer Ipsita Roymoulik Ph.D.Sr. VP of CMC & QUALITYMore ExecutivesKey CompetitorsTC BiopharmNASDAQ:TCBPScinai ImmunotherapeuticsNASDAQ:SCNIAcorda TherapeuticsNASDAQ:ACORAcorda TherapeuticsNASDAQ:ACORQGamida CellNASDAQ:GMDAView All Competitors SQZ Stock Analysis - Frequently Asked Questions How have SQZ shares performed in 2024? SQZ Biotechnologies' stock was trading at $0.0199 on January 1st, 2024. Since then, SQZ shares have increased by 133.7% and is now trading at $0.0465. View the best growth stocks for 2024 here. How were SQZ Biotechnologies' earnings last quarter? SQZ Biotechnologies (NYSE:SQZ) announced its quarterly earnings data on Wednesday, November, 10th. The company reported ($8.00) EPS for the quarter, missing analysts' consensus estimates of ($5.60) by $2.40. The business earned $4.76 million during the quarter, compared to analyst estimates of $11.64 million. SQZ Biotechnologies had a negative trailing twelve-month return on equity of 119.83% and a negative net margin of 369.96%. When did SQZ Biotechnologies' stock split? SQZ Biotechnologies's stock reverse split on Friday, July 7th 2023. The 1-10 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did SQZ Biotechnologies IPO? SQZ Biotechnologies (SQZ) raised $75 million in an initial public offering on Friday, October 30th 2020. The company issued 4,400,000 shares at a price of $16.00-$18.00 per share. BofA Securities and Stifel acted as the underwriters for the IPO and BTIG was co-manager. How do I buy shares of SQZ Biotechnologies? Shares of SQZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:SQZ) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQZ Biotechnologies Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
